Is HPV-18 present in human breast cancer cell lines? by Peran, I et al.
Letter to the Editor
Is HPV-18 present in human breast cancer cell lines?
I Peran
1, A Riegel
2, Y Dai
1, R Schlegel*,1 and X Liu
1
1Department of Pathology, Georgetown University Medical Center, Washington, DC, USA;
2Department of Oncology; Lombardi Comprehensive Cancer
Center, Georgetown University Medical Center, Washington, DC, USA
British Journal of Cancer (2010) 102, 1549–1550. doi:10.1038/sj.bjc.6605671 www.bjcancer.com
Published online 20 April 2010
& 2010 Cancer Research UK
                  
Sir,
Although several studies have suggested an association between
breast cancer and human papillomavirus (HPV) infection (de
Villiers et al, 2005; Cazzaniga et al, 2009), two recent papers
published in the British Journal of Cancer (Heng et al, 2009;
Lawson et al, 2009) were particularly provocative. The authors
claimed that both primary human breast cancers and two
well-characterised breast cancer cell lines (MDA-MB-175VII and
SK-Br-3) contained HPV-18, a type of HPV found with increased
frequency in adenocarcinomas (Iwasawa et al, 1996; Burk et al,
2003).
To further characterise the MDA-MB-175VII and SK-Br-3 cell
lines for HPV-18 gene content and expression, we performed PCR
and RT–PCR to detect viral DNA and mRNA. We also included two
cell lines as controls. The HeLa cervical cancer cell line contains
HPV-18 and was used as a positive control and the C33 cervical
cancer cell line contains no detectable HPV genomes. All cell lines
were grown in 10% FBS DMEM media to approximately 85%
confluency and then harvested for DNA and RNA isolation, after
which we performed standard PCR and RT–PCR reactions using
the indicated primer sets for the early, late, and non-coding regions
of HPV-18 (see Figure 1A). For reference, we also used the exact L1
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Figure 1 Absence of HPV-18 in the MDA-MB-175VII and SK-Br-3 breast cancer cell lines. (A) HPV-18 genome structure and PCR primer sets used in
this study. (B) PCR for HPV-18 DNA in cell lines. The indicated primer sets were used to amplify the NCR, L1, E6 and E7 regions of HPV18 DNA. L1*
indicates the primer set used in the article by Heng et al.( C) Early transcripts of HPV-18 and primer sets used for RT–PCR. (D) RT–PCR for mRNAs of
HPV-18 early genes (E6 and E7).
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HPV-18 in MDA-MB-175VII and SK-Br-3 by in situ PCR.
In order to detect HPV-18 DNA, cellular DNA was isolated using
a Qiagen DNA isolation kit. After performing PCR reactions (951C
for 5min, 35 cycles: 951C for 30s, 551C for 30s and 721C for 1min,
with a final extension at 721C for 5min) using different sets of
primers, the PCR products were separated on a 2% agarose gel.
Consistent with the studies of Schneider-Gadicke and Schwarz
(1986) that mapped the genomic fragments of HPV-18 present in
HeLa cells, our primer sets were able to amplify the L1, NCR, E6
and E7 regions of HPV-18 DNA in HeLa cells (panel B). C33A
cells were uniformly negative (panel B). Surprisingly, the
MDA-MB-175VII and SK-Br-3 breast cell lines were completely
negative for HPV-18 DNA (panel B), indicating either the absence
or very low abundance of HPV-18 DNA in these cell lines. As an
internal control for verifying DNA quality isolated from the above
cell lines, we performed PCR with primers specific for human
b globin (HBG). All samples were uniformly positive for the
presence of this gene (panel B, bottom).
To address the possibility that the copy number of HPV-18
genomes was extremely low in these cells and undetectable by PCR,
we also performed more sensitive RT–PCR reactions to detect
HPV-18 mRNA. Cellular RNA was isolated by the TRIzol method,
followed by one-step RT–PCR (421C for 60min, 951C for 2min, 35
cycles: 951C for 30s, 551C for 30s and 721C for 1min, with a final
extension at 721C for 5min). PCR products were separated on a 2%
agarose gel. In HeLa cells we detected transcription products for
the two major transforming genes of HPV-18, E6 and E7 (panel D).
As expected, we also detected the long and short size variants of E6
mRNA that are generated by RNA splicing. Corresponding to our
PCR data that indicated a lack of HPV DNA in the breast cells, we
also found no evidence for expression of HPV-18 mRNA (panel D).
To validate our RNA purification, we performed RT–PCR for
GAPDH mRNA, which demonstrated that the RNA samples were
of sufficient quality to detect the expression of a single copy gene.
To conclude, HPV-18 DNA and mRNA are not detectable in the
MDA-MB-175VII and SK-Br-3 breast cancer cell lines, contra-
dicting the study of Heng et al. As the E6 and E7 genes of the high-
risk HPVs are retained and expressed in all HPV-induced cervical
cancers (Androphy et al, 1987; Banks et al, 1987; Hawley-Nelson
et al, 1989; Munger and Howley, 2002) and their cooperative
interaction is required for efficient cell immortalisation and
maintenance of the tumourigenic phenotype (Androphy et al,
1987; Banks et al, 1987; Hawley-Nelson et al, 1989; Munger and
Howley, 2002), our results strongly indicate that HPV is not an
aetiologic factor in the generation of these breast tumour cell lines.
Although there may be a subset of breast cancers that are induced
by HPV, the MDA-MB-175VII and SK-Br-3 cell lines clearly cannot
be used to support this hypothesis and they are not valid cell lines
for studying HPV-mediated transformation of breast cells.
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